Metabolic Syndrome In Egyptian Patients with Primary Knee Osteoarthritis

Authors

  • Tamer Omar ElSaid Departments of Rheumatology & Rehabilitation, Mansoura University, Egypt
  • Shereen Mohamed Olama Departments of Rheumatology & Rehabilitation, Mansoura University, Egypt
  • Ahmed Mohamed Elewa Clinical Pathology, Faculty of Medicine, Mansoura University, Egypt

DOI:

https://doi.org/10.12970/2310-9874.2013.01.01.2

Keywords:

 Egyptian, WOMAC, Kellgren-Lawrence, Osteoarthritis, Metabolic syndrome.

Abstract

Introduction: Osteoarthritis (OA) is among the most common musculoskeletal disorders affecting millions of people throughout different races in different ages and sexes

Aim: The aim of the present study was to determine the prevalence of Metabolic Syndrome (MetS) in a group of Egyptian patients with primary knee Osteoarthritis (OA) and to detect its relation to the clinical, functional and radiographic findings.

Patients and methods: The present study included 380 patients (150 males, 230 females) diagnosed as having primary knee OA. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was used to assess disease specific self-reported disability. X-rays were classified according to the Kellgren–Lawrence (KL) radiographic rating scale. 400 (260females, 140 males) apparently healthy volunteers without knee OA were used as control group.

Results: MetS was prevalent in 53.7 % of the studied OA patients, in the control group was 37.3% of (P: <0.001). The prevalence of individual MetS components included 68.7 % for abdominal obesity, 66.8 % for hypertension, 36.1 % for hyperglycemia, 52.1 % for elevated triglycerides and 49.2 % for low high density lipoprotein (HDL). Patients with MetS had significantly higher body mass index (BMI) (P: 0.0013), longer disease duration (P: 0.021), more pain (P: 0.007), more stiffness (P: 0.043), worse functional impairment scores(P: 0.017) and advanced radiological progress (P:0.0001).

Conclusions: MetS is prevalent in patients with primary knee OA. It is associated with poor clinical performance and advanced radiological changes. The most common component of MetS in our study is abdominal obesity.

References

Suri P, Morgenroth DC, Hunter DJ. Epidemiology of osteoarthritis and associated comorbidities. PM R 2012; 4(5 Suppl): S10-9.

Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011; 7: 33-42. http://dx.doi.org/10.1038/nrrheum.2010.196

Rai MF, Sandell LJ. Inflammatory mediators: tracing links between obesity and osteoarthritis. Crit Rev Eukaryot Gene Expr 2011; 21: 131-42. http://dx.doi.org/10.1615/CritRevEukarGeneExpr.v21.i2.30

Gkretsi V, Simopoulou T, Tsezou A. Lipid metabolism and osteoarthritis: lessons from atherosclerosis. Prog Lipid Res 2011; 50: 133-40. http://dx.doi.org/10.1016/j.plipres.2010.11.001

Issa RI, Griffin TM. Pathobiology of obesity and osteoarthritis: integrating biomechanics and inflammation. Pathobiol Aging Age Relat Dis 2012 9; 2(2012) doi:pii: 17470.

Yusuf E. Metabolic factors in osteoarthritis: obese people do not walk on their hands. Arthritis Res Ther 2012; 14: 123.

Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013; 21: 16-21. http://dx.doi.org/10.1016/j.joca.2012.11.012

Gheita TA, El-Fishawy HS, Nasrallah MM, Hussein H. Insulin resistance and metabolic syndrome in primary gout: relation to punched-out erosions. Int J Rheum Dis 2012; 15: 521-5. http://dx.doi.org/10.1111/1756-185X.12007

Gheita TA, Raafat HA, Sayed S, El-Fishawy H, Nasrallah MM, Abdel-Rasheed E. Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus. Effect on carotid intima-media thickness. Z Rheumatol 2013; 72: 172-7. http://dx.doi.org/10.1007/s00393-012-1058-9

Zayed S H, Younis G, Bader R, Amin A. Prevalence of preclinical renal dysfunction in obese Egyptian patients with primary knee osteoarthritis, preliminary data. The Egyptian Rheumatologist, In Press, Corrected Proof, Available online 6 August 2013.

Zhuo Q, Yang W, Chen J, Wang Y. Metabolic syndrome meets osteoarthritis. Nat Rev Rheumatol 2012; 8: 729-37. http://dx.doi.org/10.1038/nrrheum.2012.135

Altman R, Asch E, Bloch D, et al. Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039-49. http://dx.doi.org/10.1002/art.1780290816

Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. J Rheumatol 1988; 15: 1833-40.

Grundy SM, Cleeman JI, Daniels SR, Donato KA, et al. American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-52. http://dx.doi.org/10.1161/CIRCULATIONAHA.105.169404

Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957; 16: 494-502. http://dx.doi.org/10.1136/ard.16.4.494

Puenpatom RA, Victor TW. Increased Prevalence of Metabolic Syndrome in Individuals with Osteoarthritis: An Analysis of NHANES III Data. Postgrad Med 2009; 121: 9-20. http://dx.doi.org/10.3810/pgm.2009.11.2073

Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T. Association of knee osteoarthritis with the accumulation of metabolic risk factors such as overweight, hypertension, dyslipidemia, and impaired glucose tolerance in Japanese men and women: the ROAD study. J Rheumatol 2011; 38: 921-30. http://dx.doi.org/10.3899/jrheum.100569

Engström G, Gerhardsson de Verdier M, Rollof J, Nilsson PM, Lohmander LS. C-reactive protein, metabolic syndrome and incidence of severe hip and knee osteoarthritis. A population-based cohort study. Osteoarthritis Cartilage 2009; 17: 168-73. http://dx.doi.org/10.1016/j.joca.2008.07.003

Dahaghin S, Bierma-Zeinstra SM, Koes BW, Hazes JM, Pols HA. Do metabolic factors add to the effect of overweight on hand osteoarthritis? The Rotterdam Study. Ann Rheum Dis 2007; 66: 916-20. http://dx.doi.org/10.1136/ard.2005.045724

Griffin TM, Huebner JL, Kraus VB, Yan Z, Guilak F. Induction of osteoarthritis and metabolic inflammation by a very high fat diet in mice: effects of short-term exercise. Arthritis Rheum 2012; 64: 443-53. http://dx.doi.org/10.1002/art.33332

Downloads

Published

2013-02-02

Issue

Section

Articles